Jane Street’s scPharmaceuticals SCPH Stock Holding History

Jane Street’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-200,800	Closed	-$1.14M	–	12233
2025 Q3	$1.14M	Buy	200,800 +187,900	+1,457%	+$962K	﹤0.01%	6034
2025 Q2	$49.1K	Buy	+12,900	New	+$40K	﹤0.01%	9178
2023 Q3	–	Sell	-12,600	Closed	-$128K	–	9290
2023 Q2	$128K	Buy	+12,600	New	+$131K	﹤0.01%	7889

Jane Street's SCPH Position: Q3 2025 in Review

Jane Street sold out of scPharmaceuticals (SCPH) in Q3 2025, closing a stake of 23,208 shares — an estimated $119K sold.

Jane Street first reported a position in SCPH in Q4 2022 and held it in 9 quarters. The position peaked at $1.37M in Q1 2023. 109 funds tracked by Wall St. Rank hold SCPH as of Q3 2025.

Jane Street reported no remaining scPharmaceuticals position as of Q3 2025 after selling out during the quarter.
Jane Street sold 23,208 scPharmaceuticals shares in Q3 2025, an estimated $119K.
Jane Street first reported a position in scPharmaceuticals in Q4 2022 and held it in 9 quarters.
Jane Street's scPharmaceuticals position peaked at $1.37M in Q1 2023.
109 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.